BioCentury | Feb 12, 2021
Deals

Feb. 11 Quick Takes: First day pop for Bioventus; plus venture rounds for Pipeline, Immunai, Sanofi, i2O, AZ’s trimmings, Truveta

...a series A round led by Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management and Dexcel Pharma...
BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...I diabetes; and one from NIH: KT-A522 for Type II diabetes and obesity. QVT and Dexcel Pharma...
...Corporate partners: N/A Number of employees: 8 Funds raised: More than $80.5 million Investors: QVT, Dexcel Pharma...
BioCentury | Feb 9, 2018
Company News

Verge, Datavant in data analysis partnership

...corporate development lead. After raising $1.1 billion in equity financing from SoftBank Vision Fund and Dexcel Pharma...
BioCentury | Jan 5, 2018
Company News

Verge, Datavant in data analysis partnership

...corporate development lead. After raising $1.1 billion in equity financing from SoftBank Vision Fund and Dexcel Pharma...
BioCentury | Aug 11, 2017
Finance

Building adVANTage

...Roivant raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
...founder and CEO Vivek Ramaswamy, Roivant raised $90 million in May 2014 from QVT Fund, Dexcel Pharma...
BioCentury | Aug 11, 2017
Financial News

Roivant raises $1.1B in equity financing

...Switzerland) raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
BioCentury | Aug 9, 2017
Financial News

Roivant raises $1.1B in equity financing

...Switzerland) raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
BioCentury | Apr 6, 2015
Financial News

Cynapsus completes private placement

...Advisors; Aisling Capital ; Venrock; Broadfin Capital; Sphera Global Healthcare Fund; DAFNA Capital Management LLC; Dexcel Pharma WIR...
BioCentury | Apr 21, 2014
Financial News

Cynapsus completes private placement of units

...after offering: 78.6 million Placement agents: M Partners; Noble Financial Capital Markets Investors: Institutional investors; Dexcel Pharma...
...comprises a share and a five-year warrant to purchase a share at C$0.81. Existing investor Dexcel Pharma...
BioCentury | May 20, 2013
Company News

Cynapsus board of directors update

...Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Appointed: Tomer Gold, VP of R&D at Dexcel Pharma...
Items per page:
1 - 10 of 12
BioCentury | Feb 12, 2021
Deals

Feb. 11 Quick Takes: First day pop for Bioventus; plus venture rounds for Pipeline, Immunai, Sanofi, i2O, AZ’s trimmings, Truveta

...a series A round led by Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management and Dexcel Pharma...
BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...I diabetes; and one from NIH: KT-A522 for Type II diabetes and obesity. QVT and Dexcel Pharma...
...Corporate partners: N/A Number of employees: 8 Funds raised: More than $80.5 million Investors: QVT, Dexcel Pharma...
BioCentury | Feb 9, 2018
Company News

Verge, Datavant in data analysis partnership

...corporate development lead. After raising $1.1 billion in equity financing from SoftBank Vision Fund and Dexcel Pharma...
BioCentury | Jan 5, 2018
Company News

Verge, Datavant in data analysis partnership

...corporate development lead. After raising $1.1 billion in equity financing from SoftBank Vision Fund and Dexcel Pharma...
BioCentury | Aug 11, 2017
Finance

Building adVANTage

...Roivant raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
...founder and CEO Vivek Ramaswamy, Roivant raised $90 million in May 2014 from QVT Fund, Dexcel Pharma...
BioCentury | Aug 11, 2017
Financial News

Roivant raises $1.1B in equity financing

...Switzerland) raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
BioCentury | Aug 9, 2017
Financial News

Roivant raises $1.1B in equity financing

...Switzerland) raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
BioCentury | Apr 6, 2015
Financial News

Cynapsus completes private placement

...Advisors; Aisling Capital ; Venrock; Broadfin Capital; Sphera Global Healthcare Fund; DAFNA Capital Management LLC; Dexcel Pharma WIR...
BioCentury | Apr 21, 2014
Financial News

Cynapsus completes private placement of units

...after offering: 78.6 million Placement agents: M Partners; Noble Financial Capital Markets Investors: Institutional investors; Dexcel Pharma...
...comprises a share and a five-year warrant to purchase a share at C$0.81. Existing investor Dexcel Pharma...
BioCentury | May 20, 2013
Company News

Cynapsus board of directors update

...Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Appointed: Tomer Gold, VP of R&D at Dexcel Pharma...
Items per page:
1 - 10 of 12